Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous sclerosis

Nephrology Dialysis Transplantation

Volumn 12, Issue 11, 1997, Pages 2284-2288

  Griffin, M D ^a   Gamble, V ^c   Milliner, D S ^a   Gomez, M R ^b   Harris, P C ^c   Torres, V E ^a,b  

^a Division of Nephrology   (United States)

^b MAYO CLINIC   (United States)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Hereditary disease; Linkage analysis; PKD1; Polycystic kidney disease; TSC2; Tuberous sclerosis

Indexed keywords

DNA;

ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 16; CLINICAL ARTICLE; DISEASE COURSE; ECHOGRAPHY; EPILEPSY; FAMILY HISTORY; FEMALE; GENE DELETION; GENE LOCUS; GENETIC COUNSELING; GENETIC LINKAGE; HUMAN; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; MALE; NEWBORN; NEWBORN DISEASE; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; LINKAGE (GENETICS); MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TUBEROUS SCLEROSIS;

EID: 0030656588     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.11.2284     Document Type: Article

References (24)

1. Zerres K, Rudnik-Schöneborn. On genetic heterogeneity, anti-cipation, and imprinting in polycystic kidney diseases. Nephrol Dial Transplant 1995; 10: 7-9
2. Brook-Carter PT, Peral B, Ward CJ et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nature Genet 1994; 8: 328-332
3. The European polycystic kidney disease consortium: the polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994; 77: 881-894
4. Fick GM, Johnson AM, Gabow PA. Is there evidence for anticipation in autosomal dominant polycystic kidney disease. Kidney Int 1994; 45: 1153-1162
5. Torra R, Bandenas C, Darnell A et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 1996; 7: 2142-2151
6. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995; 81: 289-298
7. The American PKD1 Consortium. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PDK1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 1995; 4: 575-582
8. Hughes J, Ward CJ, Peral B et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genet 1995; 10: 151-160
9. Mochizuki T, Guanqing W, Tomohito H et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342
10. Geberth S, Ritz E, Zeier M, Stier E. Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? Nephrol Dial Transplant 1995; 10: 1603-1606
11. Kwiatkowski DJ, Henske EP, Weimer K, Ozelius L, Gusella JF, Haines J. Construction of a GT polymorphism map of human 9q. Genomics 1992; 12: 229-240
12. Peral B, Ward CJ, San Millán JL et al. Evidence of linkage disequilibrium in the Spanish polycystic kidney disease 1 (PKD1) population. Am J Human Genet 1994; 54: 899-908
13. Fick GM, Johnson, Strain JD et al. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1863-1870
14. Chapman AB. Particular problems in childhood and adolescence in autosomal dominant polycystic kidney disease. In: Watson ML, Torres VE (eds.), Polycystic Kidney Disease. Oxford Medical Publications, Oxford, 1996; 548-567
15. Peters DJM, Sandkuijl LA. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 1992; 97: 128-139
16. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305-1315
17. Harris PC, Ward CJ, Peral B, & Hughes J. Autosomal dominant polycystic kidney disease: molecular analysis. Human Mol Genet 1995; 4: 1745-1749
18. Tsuchida H, Orimoto K, Kobayashi K, Hino O. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (TSC2] gene product of the Eker rat model. Cancer Res 1996; 56: 429-433
19. Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992; 68: 799-808
20. Peral B, Ong ACM, San Millán JL, Gamble V, Rees L, Harris PC. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 1996; 5: 539-542
21. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 1996; 87: 979-987
22. Iakoubova OA, Dushkin H, Beier DR. Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity. Genomics 1995; 26: 107-114
23. Birkenmeier EH Janaswam P. Role of modifier genes in PKD. Kidney Int 1996; 49: 731-732
24. Guay-Woodford LM, Bryda EC, Christine B et al. Evidence that two phenotypically distinct mouse PKD mutations bpk and jcpk, are allelic. Kidney Int 1996; 50: 1158-1165